114 related articles for article (PubMed ID: 16904225)
1. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
2. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.
Ren F; Zhao S; He X; Lo H; Wong VKW; Law BYK; Wu A; Zhang J
J Med Virol; 2024 May; 96(5):e29669. PubMed ID: 38773784
[TBL] [Abstract][Full Text] [Related]
3. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.
Yu X; Gong Q; Yu D; Chen Y; Jing Y; Zoulim F; Zhang X
Gut; 2024 Apr; 73(5):797-809. PubMed ID: 37968095
[TBL] [Abstract][Full Text] [Related]
4. Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters.
Giraud G; El Achi K; Zoulim F; Testoni B
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675956
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C
Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063
[TBL] [Abstract][Full Text] [Related]
6. cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels.
Ren EC; Zhuo NZ; Goh ZY; Bonne I; Malleret B; Ko HL
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892121
[TBL] [Abstract][Full Text] [Related]
7. Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes.
Liu ZJ; Xu Y; Wang WX; Guo B; Zhang GY; Luo GC; Wang Q
World J Gastrointest Oncol; 2023 Aug; 15(8):1486-1496. PubMed ID: 37663947
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA.
Bianca C; Sidhartha E; Tiribelli C; El-Khobar KE; Sukowati CHC
World J Hepatol; 2022 May; 14(5):866-884. PubMed ID: 35721287
[TBL] [Abstract][Full Text] [Related]
9. Circular RNAs regulate cancer-related signaling pathways and serve as potential diagnostic biomarkers for human cancers.
Garlapati P; Ling J; Chiao PJ; Fu J
Cancer Cell Int; 2021 Jun; 21(1):317. PubMed ID: 34162394
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression.
Hsu CW; Chu YD; Lai MW; Lin CL; Liang KH; Lin YH; Yeh CT
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572617
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Circular RNAs in Cancer.
Liu J; Zhang X; Yan M; Li H
Front Oncol; 2020; 10():663. PubMed ID: 32670861
[TBL] [Abstract][Full Text] [Related]
12. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
[TBL] [Abstract][Full Text] [Related]
13. SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation.
Yang H; Mo J; Xiang Q; Zhao P; Song Y; Yang G; Wu K; Liu Y; Liu W; Wu J
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121397
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
Vatansever S; Farajov R; Yılmaz HC; Zeytunlu M; Paköz ZB; Kılıç M
Turk J Gastroenterol; 2019 Jan; 30(1):75-80. PubMed ID: 30644364
[TBL] [Abstract][Full Text] [Related]
15. Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues.
Tantiwetrueangdet A; Panvichian R; Sornmayura P; Sueangoen N; Leelaudomlipi S
Med Oncol; 2018 Aug; 35(10):127. PubMed ID: 30116916
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of preoperative positron emission tomography uptake in hepatectomy patients.
Kim JM; Kwon CHD; Joh JW; Sinn DH; Choi GS; Paik SW
Ann Surg Treat Res; 2018 Apr; 94(4):183-189. PubMed ID: 29629352
[TBL] [Abstract][Full Text] [Related]
17. Detection of HBV Covalently Closed Circular DNA.
Li X; Zhao J; Yuan Q; Xia N
Viruses; 2017 Jun; 9(6):. PubMed ID: 28587292
[TBL] [Abstract][Full Text] [Related]
18. Update on occult hepatitis B virus infection.
Makvandi M
World J Gastroenterol; 2016 Oct; 22(39):8720-8734. PubMed ID: 27818588
[TBL] [Abstract][Full Text] [Related]
19. Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence.
Wang Q; Lin L; Yoo S; Wang W; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu J; Hiotis SP
Br J Cancer; 2016 Sep; 115(7):841-7. PubMed ID: 27537392
[TBL] [Abstract][Full Text] [Related]
20. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
